Contribution of the addition of anti-ββ2-glycoprotein to the classification of antiphospholipid syndrome in predicting adverse pregnancy outcome

被引:5
作者
Oron, Galia [4 ]
Ben-Haroush, Avi [1 ,4 ]
Goldfarb, Rachel [4 ]
Molad, Yair [2 ,4 ]
Hod, Moshe [4 ]
Bar, Jacob [3 ,4 ]
机构
[1] Helen Schneider Hosp Women, Rabin Med Ctr, Perinatal Div, IL-49100 Petah Tiqwa, Israel
[2] Rabin Med Ctr, Rheumatol Unit, Lupus Clin, Petah Tiqwa, Israel
[3] Wolfson Med Ctr, Perinatal Div, Holon, Israel
[4] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
Anti-beta; 2; glycoprotein; 1; antiphospholipid syndrome; pregnancy; complications; INTERNATIONAL CONSENSUS STATEMENT; SYSTEMIC-LUPUS-ERYTHEMATOSUS; EUROPEAN-FORUM; ANTIBODIES; CRITERIA; RISK; ANTI-BETA(2)-GLYCOPROTEIN-I; AUTOANTIBODIES; ASSOCIATION; UPDATE;
D O I
10.3109/14767058.2010.511339
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Methods. aEuro integral A retrospective cohort design was used. Ninety-one patients (total 394 pregnancies) referred to a tertiary medical center for evaluation of clinical features consistent with APS were divided into three groups: group A (n == 34), two positive tests for anticardiolipin (ACL) or lupus anticoagulant (LAC), in accordance with original APS classification (1998); group B (n == 18), two positive tests for a-beta beta 2GP1, in accordance with the revised APS criteria; and group C (n == 39), only one positive test for ACL or LAC. Results. aEuro integral Of the 52 women with APS (group A or B), 36 had primary disease, and 16 had secondary disease. On comparison of the groups, group B was characterized by a significantly higher rate of complicated pregnancy (83.3%%) than groups A (47.1%%) and C (76.9%%), P == 0.007, and a higher rate of fetal loss (72.2%%) than groups A ++ C (28.8%%, P == 0.001). Conclusions. aEuro integral The findings suggest that the revised APS criteria are preferable to the original classification for the prediction of complicated pregnancy.
引用
收藏
页码:606 / 609
页数:4
相关论文
共 50 条
  • [31] Antiphospholipid syndrome: antibodies to Domain 1 of β2-glycoprotein 1 correctly classify patients at risk
    Pengo, V.
    Ruffatti, A.
    Tonello, M.
    Cuffaro, S.
    Banzato, A.
    Bison, E.
    Denas, G.
    Jose, S. Padayattil
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (05) : 782 - 787
  • [32] Anti-β2-glycoprotein I paratopes and β2-glycoprotein I epitopes characterization using random peptide libraries
    Zager, Urska
    Kveder, Tanja
    Cucnik, Sasa
    Bozic, Borut
    Lunder, Mojca
    AUTOIMMUNITY, 2014, 47 (07) : 438 - 444
  • [33] Anti-β2-glycoprotein I ELISA assay: The influence of different antigen preparations
    Cavazzana, Anna
    Pengo, Vittorio
    Tonello, Marta
    Noventa, Franco
    Grossi, Claudia
    Borghi, Maria Orietta
    de Moerlooses, Philippe
    Reber, Guido
    Ruffatti, Amelia
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (04) : 789 - 791
  • [34] Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome
    Pericleous, Charis
    Ferreira, Isabel
    Borghi, Orietta
    Pregnolato, Francesca
    McDonnell, Thomas
    Garza-Garcia, Acely
    Driscoll, Paul
    Pierangeli, Silvia
    Isenberg, David
    Ioannou, Yiannis
    Giles, Ian
    Meroni, Pier Luigi
    Rahman, Anisur
    PLOS ONE, 2016, 11 (06):
  • [35] Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome
    Iwaniec, Teresa
    Kaczor, Marcin P.
    Celinska-Lowenhoff, Magdalena
    Polanski, Stanislaw
    Musial, Jacek
    THROMBOSIS RESEARCH, 2017, 153 : 90 - 94
  • [36] The clinical value of assays detecting antibodies against domain I of β2-glycoprotein I in the antiphospholipid syndrome
    Yin, Dongmei
    de Laat, Bas
    Devreese, Katrien M. J.
    Kelchtermans, Hilde
    AUTOIMMUNITY REVIEWS, 2018, 17 (12) : 1210 - 1218
  • [37] Characteristics and pathogenic role of anti-β2-glycoprotein I single-chain Fv domains:: induction of experimental antiphospholipid syndrome
    Blank, M
    Waisman, A
    Mozes, E
    Koike, T
    Shoenfeld, Y
    INTERNATIONAL IMMUNOLOGY, 1999, 11 (12) : 1917 - 1926
  • [38] IgG anti-β2-glycoprotein I antibodies in adult patients with systemic lupus erythematosus:: Prevalence and diagnostic value for the antiphospholipid syndrome
    Tubach, F
    Hayem, G
    Marchand, JL
    Weber, M
    Palazzo, E
    de Bandt, M
    Roux, S
    Kahn, MF
    Meyer, O
    JOURNAL OF RHEUMATOLOGY, 2000, 27 (06) : 1437 - 1443
  • [39] Anti-β2-glycoprotein I antibodies:: clinical significance
    Tincani, A
    Spatola, L
    Cinquini, M
    Cattaneo, R
    Meroni, P
    Balestrieri, G
    LUPUS, 1998, 7 : S107 - S109
  • [40] Role of β2-glycoprotein I in the pathogenesis of the antiphospholipid syndrome
    Li, Jing
    Zhu, Xiangrui
    Feng, Juan
    RHEUMATOLOGY & AUTOIMMUNITY, 2023, 3 (03): : 131 - 139